Chandler, AZ, United States of America

Daniela Bockenstedt

This inventor holds 1 USPTO granted patent. Top assignee: Insys Development Company, Inc.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniela Bockenstedt. Retrieved from https://idiyas.com/inventor/daniela-bockenstedt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Daniela Bockenstedt: Innovator in Pain Management

Introduction

Daniela Bockenstedt is a notable inventor based in Chandler, AZ (US). She has made significant contributions to the field of pain management through her innovative work. Her dedication to improving patient care is evident in her patented invention.

Latest Patents

Daniela holds a patent for a diclofenac sublingual spray. This invention is directed to diclofenac sublingual spray formulations. It also encompasses methods for treating pain and inflammation by administering these formulations to patients in need.

Career Highlights

She is currently associated with Insys Development Company, Inc., where she continues to advance her research and development efforts. Daniela's work is pivotal in creating effective solutions for pain relief.

Collaborations

Some of her coworkers include Kiran Kumar Vangara and Ningxin Yan, who contribute to her innovative projects.

Conclusion

Daniela Bockenstedt's contributions to the field of pain management through her patented diclofenac sublingual spray highlight her commitment to improving patient outcomes. Her work exemplifies the impact of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…